ProfileOfResearchers

TÃTULO: High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 Trial
AUTORES: Roelof Willemze; Stefan Suciu; Giovanna Meloni; Boris Labar; Jean Pierre Marie; Constantijn J M Halkes; Petra Muus; Martin Mistrik; Sergio Amadori; Giorgina Specchia; Francesco Fabbiano; Francesco Nobile; Marco Sborgia; Andrea Camera; Dominik L D Selleslag; Francois Lefrere; Domenico Magro; Simona Sica; Nicola Cantore; Meral Beksac; Zwi Berneman; Xavier Thomas; Lorella Melillo; Jose E Guimaraes; Pietro Leoni; Mario Luppi; Maria E Mitra; Dominique Bron; Georges Fillet; Erik W A Marijt; Adriano Venditti; Anne Hagemeijer; Marco Mancini; Joop Jansen; Daniela Cilloni; Liv Meert; Paola Fazi; Marco Vignetti; Silvia M Trisolini; Franco Mandelli; Theo de Witte; ...Mais
PUBLICAÇÃO: 2014, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 32, NÚMERO: 3

INDEXADO EM:

Scopus

WOS

TÃTULO: High Dose (HD-AraC) Vs Standard Dose Cytosine Arabinoside (SD-AraC) During Induction and IL-2 Vs Observation After Consolidation/Autologous Stem Cell Transplantation in Patients with Acute Myelogenous Leukemia (AML): Final Report of the AML-12 Trial of EORTC and GIMEMA Leukemia Groups on the Value of High Dose AraC
AUTORES: Roelof Willemze; Stefan Suciu; Franco Mandelli; Giovanna Meloni; Boris Labar; Stijn J M Halkes; Petra Muus; Martin Mistrik; Giorgina Specchia; Francesco Fabbiano; Francesco Nobile; Marco Sborgia; Andrea Camera; Dominik Selleslag; Francois Lefrere; Domenico Magro; Giuseppe Leone; Nicola Cantore; Meral Beksac; Zwi Berneman; Xavier Thomas; Lorella Melillo; Dominique Bron; Georges Fillet; Jose E Guimaraes; Sergio Amadori; Paola Fazi; Matthias Karrasch; Marco Vignetti; Theo de Witte; Jean Pierre Marie; ...Mais
PUBLICAÇÃO: 2011, FONTE: 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis in BLOOD, VOLUME: 118, NÚMERO: 21

INDEXADO EM:

WOS

TÃTULO: High Dose (HD-AraC) Vs Standard Dose Cytosine Arabinoside (SD-AraC) during Induction and Value of IL-2 during Maintenance in Acute Myelogenous Leukemia (AML): Impact of AraC Dose on Complete Remission Rate and Toxicity (Results on the first 1700 randomized patients of the AML-12 trial of EORTC and GIMEMA Leukemia Groups)
AUTORES: Roelof Willemze; Stefan Suciu; Franco Mandelli; Boris Labar; Jean Pierre Marie; Martin Mistrik; Vincenzo Liso; Francesco Fabbiano; Francesco Nobile; Marco Sborgia; Bruno Rotoli; Dominik L D Selleslag; Francois Lefrere; Antonio Peta; Massimo F Martelli; Giuseppe Leone; Nicola Cantore; Meral Beksac; Berneman Zwi; Xavier Thomas; Michele Mario Greco; Dominique Bron; Georges Fillet; Jose E Guimaraes; Petra Muus; Paola Fazi; Liliana Baila; Marco Vignetti; Sergio Amadori; Theo de Witte; Giovanna Meloni; ...Mais
PUBLICAÇÃO: 2008, FONTE: 50th Annual Meeting of the American-Society-of-Hematology in BLOOD, VOLUME: 112, NÚMERO: 11

INDEXADO EM:

WOS

Links Úteis